Coya Therapeutics (COYA) Current Taxes (2023 - 2024)
Coya Therapeutics (COYA) reported Current Taxes of $723852.0 for Q1 2024, little changed sequentially from $723852.0 in Q4 2023.
Coya Therapeutics (COYA) Current Taxes (2023 - 2024) Analysis & Trends
Coya Therapeutics (COYA) has 2 years of Current Taxes data on file, last reported at $723852.0 in Q1 2024.
- For the quarter ending Q1 2024, Current Taxes changed N/A year-over-year to $723852.0; the trailing twelve-month figure through Mar 2024 stood at $723852.0 (changed N/A YoY), and the FY2023 full-year result was $723852.0, changed N/A from the prior year.
- Current Taxes was little changed at $723852.0 in Q1 2024, from $723852.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $723852.0 in Q4 2023 to a low of $723852.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 63.52 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 723,852.00 |
| Dec 31, 2023 | 723,852.00 |